// App-Quantinova.ai

TCT-177 : Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Lesions: Final 2-Year Results From the Disrupt CAD III Study

Researchers

Presenter

  • Dean Kereiakes

Principal Investigators

  • Jonathan Hill

  • Richard Shlofmitz

  • Andrew Klein

  • Robert Riley

  • Matthew Price

  • Howard Herrmann

  • William Bachinsky

  • Ron Waksman

  • Gregg Stone

Medical Centers

  • St. Francis Hospital, Roslyn, New York, USA

  • The Royal Marsden Hospital, London, United Kingdom

  • Piedmont Heart, Atlanta, Georgia, USA

  • The Christ Hospital Heart and Vascular Center, Cincinnati, Ohio, USA

  • Mount Sinai Heart Health System, New York, New York, USA

  • Overlake Medical Center, Sammamish, Washington, USA

  • MedStar Heart Institute, Washington, District of Columbia, USA

  • Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA

  • University of Pittsburgh Medical Center, Pinnacle CardioVascular Institute, Harrisburg, Pennsylvania, USA

  • Scripps Clinic, La Jolla, California, USA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Complex calcified coronary artery lesions

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Arm

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved